Tes Pharma is a research-based biotech, founded in 2011 by Professor Roberto Pellicciari, focused on delivering proprietary first-in-class drug candidates for oncology, renal  and metabolic diseases. 

Tes Pharma’s fully integrated scientific  team translates expertise in cellular and molecular biology, medicinal, computational and analytical chemistry in the discovery  
of innovative therapies.

Tes Pharma has a broad portfolio of drug discovery projects based on in-house research that are unlocking the potential of novel therapeutic targets, including orphan nuclear receptors. 

Biotechnology

Clinical Trials

Tes Pharma S.r.l.

Org chart

Similar companies